Search Results - "Dolotovskaya, P V"

Refine Results
  1. 1
  2. 2

    The “Inverse” Seasonal Blood Pressure Variability Phenotype by Gorbunov, V. M., Smirnova, M. I., Koshelyaevskaya, Y. N., Panueva, N. N., Furman, N. V., Dolotovskaya, P. V.

    “…The seasonal blood pressure variability (BPV) is known to demonstrate a typical winter peak. Recently, more attention is paid to the opposite situation: the…”
    Get full text
    Journal Article
  3. 3

    Characteristics of Patients with Reproducible Masked Hypertension and its Diagnosis Approach by Smirnova, М. I., Gorbunov, V. M., Koshelyaevskaya, Ya. N., Deev, A. D., Volkov, D. A., Furman, N. V., Dolotovskaya, P. V.

    “…Background. Early diagnostics of masked hypertension (MH) is one of the key problems in modern cardiology due to the association of this blood pressure (BP)…”
    Get full text
    Journal Article
  4. 4

    ADP-Induced Recalcified Blood Clotting Time as a Marker of Rethrombosis Risk and Effectiveness of Antiplatelet Therapy in Acute Coronary Syndrome by Malinova, L I, Furman, N V, Dolotovskaya, P V, Chernousova, L A, Denisova, T P

    Published in Kardiologiia (01-01-2018)
    “…to assess the possibility of the use of ADP induced blood-clotting time measurement in clinical practice prognostication of the course of acute coronary…”
    Get more information
    Journal Article
  5. 5

    ANTIPLATELET TREATMENT IN ST ELEVATION ACUTE CORONARY SYNDROME UNDER REAL CLINICAL CIRCUMSTANCES: THE DYNAMICS OF THROMBOCYTE FUNCTION by Malinova, L. I., Furman, N. V., Dolotovskaya, P. V., Puchinian, N. F., Radaeva, I. Yu

    “…Aim. To evaluate the dynamics of thrombocyte functional activity (TFA) under antiplatelet treatment conditions which include the branded, and generic compounds…”
    Get full text
    Journal Article
  6. 6

    MONITORING OF THE EFFECTIVENESS OF ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE by Puchinian, N. F., Furman, N. V., Malinova, L. I., Dolotovskaya, P. V.

    “…Monitoring of the effectiveness of drug therapy is one of the most debated issues in everyday clinical practice. The emergence of new drugs,  methods of…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    PHARMACOTHERAPY AND OUTCOMES OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION – GENDER DIFFERENCES IN REAL CLINICAL PRACTICE by Dolotovskaya, P. V., Rudnichenko, E. Y., Furman, N. V., Reshet'ko, O. V.

    “…Aim. To analyze gender differences in pharmacotherapy and outcomes of ST-elevation myocardial infarction (STEMI) in patients of cardiology hospital in real…”
    Get full text
    Journal Article
  10. 10

    RISK OF RECURRENT THROMBOTIC EVENTS IN PATIENTS WITH ACUTE CORONARY SYNDROME AND HIGH PLASMA LEVELS OF D-DIMER by Panina, A. V., Puchinyan, N. F., Dovgalevskyi, Ya. P., Furman, N. V., Dolotovskaya, P. V., Malinova, L. I.

    “…Aim. To study the association of plasma D-dimer levels and the risk of thrombotic events in patients hospitalised with acute coronary syndrome (ACS). Material…”
    Get full text
    Journal Article
  11. 11
  12. 12

    RISK OF THROMBOEMBOLIC COMPLICATIONS AND ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT AND RECURRENT ATRIAL FIBRILLATION IN REAL CLINICAL PRACTICE by Grajfer, I. V., Kuvshinova, L. E., Dolotovskaya, P. V., Reshet'ko, O. V., Furman, N. V.

    “…Aim. Тo evaluate compliance of ongoing antithrombotic therapy (ATT) in various forms of atrial fibrillation (AF) with the risk level of thromboembolic…”
    Get full text
    Journal Article
  13. 13
  14. 14

    PHARMACOTHERAPY ANALYSIS OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION IN HOSPITALS OF VARIOUS TYPES by Magdeev, R. M., Reshetko, O. V., Rudnichenko, E. Y., Furman, N. V., Dolotovskaya, P. V., Grozdova, T. Y., Volkova, L. N.

    “…Aim. To evaluate pharmacotherapy of ST-elevation myocardial infarction (STEMI) in cardiology departments of Saratov hospitals of various types. Material and…”
    Get full text
    Journal Article
  15. 15

    P808Characteristics of patients with reproducible masked hypertension by Smirnova, M I, Gorbunov, V M, Volkov, D A, Koshelyaevskaya, Y N, Deev, A D, Furman, N V, Dolotovskaya, P V

    Published in European heart journal (01-10-2019)
    “…Abstract Background Masked hypertension (MH) is associated with cardiovascular complications and poor prognosis. Characteristics of untreated patients with…”
    Get full text
    Journal Article
  16. 16

    THE ADHERENCE TO RECOMMENDED THERAPY IN PATIENTS AFTER ACUTE CORONARY SYNDROME, AND RISK OF CARDIOVASCULAR COMPLICATIONS WITHIN A YEAR AFTER HOSPITAL ADMISSION by N. F. Puchin'yan, Ya. P. Dovgalevskiy, P. V. Dolotovskaya, N. V. Furman

    “…Aim. In patients after acute coronary syndrome (ACS) to study the effect of adherence to recommended therapy on the risk of cardiovascular events during a year…”
    Get full text
    Journal Article
  17. 17

    RISK OF THROMBOEMBOLIC COMPLICATIONS AND ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT AND RECURRENT ATRIAL FIBRILLATION IN REAL CLINICAL PRACTICE by I. V. Grajfer, L. E. Kuvshinova, P. V. Dolotovskaya, O. V. Reshet'ko, N. V. Furman

    “…Aim. Тo evaluate compliance of ongoing antithrombotic therapy (ATT) in various forms of atrial fibrillation (AF) with the risk level of thromboembolic…”
    Get full text
    Journal Article
  18. 18

    PHARMACOTHERAPY AND OUTCOMES OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION – GENDER DIFFERENCES IN REAL CLINICAL PRACTICE by P. V. Dolotovskaya, E. Y. Rudnichenko, N. V. Furman, O. V. Reshet'ko

    “…Aim. To analyze gender differences in pharmacotherapy and outcomes of ST-elevation myocardial infarction (STEMI) in patients of cardiology hospital in real…”
    Get full text
    Journal Article
  19. 19
  20. 20